Bridgeway Capital Management, LLC Ideaya Biosciences, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$12.17 - $17.52 $547,650 - $788,400
-45,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$11.22 - $14.46 $168,300 - $216,900
-15,000 Reduced 25.0%
45,000 $565,000
Q2 2020

Aug 14, 2020
SELL
$3.59 - $18.57 $89,750 - $464,250
-25,000 Reduced 29.41%
60,000 $853,000
Q4 2019

Feb 14, 2020
BUY
$5.34 - $9.09 $186,900 - $318,150
35,000 Added 70.0%
85,000 $638,000
Q3 2019

Nov 14, 2019
BUY
$6.06 - $10.91 $303,000 - $545,500
50,000 New
50,000 $450,000

Others Institutions Holding IDYA

# of Institutions
206
Shares Held
71.2M
Call Options Held
29.8K
Put Options Held
8.5K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.69B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email